Cargando…

A Case of Tyrosine Kinase Inhibitor-Induced Bone Marrow Aplasia That Was Successfully Treated with Allogeneic Hematopoietic Stem Cell Transplantation

Here, we present a rare case of tyrosine kinase inhibitor (TKI)-induced bone marrow aplasia. A 58-year-old man presented with leukocytosis and was diagnosed with chronic myeloid leukemia. He was initially treated with imatinib for 6 years and abruptly discontinued treatment by himself. He was admini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamijo, Kimimori, Shimomura, Yoshimitsu, Yamashita, Daisuke, Ishikawa, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339493/ https://www.ncbi.nlm.nih.gov/pubmed/34413745 http://dx.doi.org/10.1159/000517442

Ejemplares similares

Clinical features and outcomes of duodenal‐type follicular lymphoma: A single‐center retrospective study
por: Kamijo, Kimimori, et al.
Publicado: (2022)

BCR/ABL1-positive B-lymphoblastic Lymphoma Successfully Treated with Dasatinib-combined Chemotherapy
por: Yamada, Chika, et al.
Publicado: (2021)

Encapsulating peritoneal sclerosis in a patient after allogeneic hematopoietic stem cell transplantation: a case report
por: Shimomura, Yoshimitsu, et al.
Publicado: (2019)

Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: An observational study
por: Nishikubo, Masashi, et al.
Publicado: (2023)

Extramedullary relapse of acute myeloid leukemia in brachial plexus after allogeneic stem cell transplantation: a case report
por: Shirota, Shogo, et al.
Publicado: (2022)

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation
por: Jung, Sung-Hoon, et al.
Publicado: (2012)

Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation
por: Kamijo, Kimimori, et al.
Publicado: (2023)

Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation
por: Szyska, Martin, et al.
Publicado: (2016)

Economic analysis of allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Center of Tunisia
por: Achour, Leila, et al.
Publicado: (2023)

Successful allogeneic bone marrow transplantation using immunosuppressive conditioning regimen for a patient with red blood cell transfusiondependent pyruvate kinase deficiency anemia
por: Shimomura, Maiko, et al.
Publicado: (2020)

Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies
por: Yanada, Masamitsu, et al.
Publicado: (2022)

Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation
por: Masouridi-Levrat, Stavroula, et al.
Publicado: (2016)

DNA methylation dynamic of bone marrow hematopoietic stem cells after allogeneic transplantation
por: Trino, Stefania, et al.
Publicado: (2019)

The cellular composition and function of the bone marrow niche after allogeneic hematopoietic cell transplantation
por: Peci, Flavia, et al.
Publicado: (2022)

Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
por: Asawapanumas, Thiti, et al.
Publicado: (2022)

Successful Treatment with Ganciclovir for Cytomegalovirus Duodenitis following Allogenic Bone Marrow Transplantation
por: Ahn, Jin Hee, et al.
Publicado: (1999)

Tyrosine Kinase Inhibitor for Treatment of Adult Allogeneic Hematopoietic Stem Cell Transplantation Candidate with Philadelphia-Positive Acute Lymphoblastic Leukemia
por: Wang, Lu, et al.
Publicado: (2017)

Characterization of Patients with Chronic Myeloid Leukemia Unresponsive to Tyrosine Kinase Inhibitors Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
por: Carvalho, Franceli Ramos, et al.
Publicado: (2017)

Primary cutaneous aspergillosis and idiopathic bone marrow aplasia
por: Furlan, Karina Colossi, et al.
Publicado: (2016)

Disseminated fusariosis in a patient with bone marrow aplasia()()
por: Chagas, Danielle Ferreira, et al.
Publicado: (2020)

Successful allogeneic bone marrow transplantation for childhood-onset refractory anemia with ringed sideroblasts.
por: Kook, H., et al.
Publicado: (2000)

The First Reported Case of Allogenic Hematopoietic Stem Cell Transplantation for CML Blast Phase (Monocytic Lineage) in the Tyrosine Kinase Inhibitor Era
por: Yamada, Shinya, et al.
Publicado: (2022)

Bone marrow aplasia following donor lymphocyte infusion in 4-year-old patient with chronic granulomatous disease after allogeneic stem cell transplantation: case report
por: CIENKUSZ, MAGDALENA, et al.
Publicado: (2020)

Direct cost analysis of the second year post-allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Centre of Tunisia
por: Razgallah Khrouf, Myriam, et al.
Publicado: (2017)

Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation
por: Gonçalves, Thissiane L, et al.
Publicado: (2009)

Allogeneic Non-Adherent Bone Marrow Cells Facilitate Hematopoietic Recovery but Do Not Lead to Allogeneic Engraftment
por: Fricke, Stephan, et al.
Publicado: (2009)

Intra-Bone Marrow Transplantation of Endosteal Bone Marrow Cells Facilitates Allogeneic Hematopoietic and Stromal Cells Engraftment Dependent on Early Expression of CXCL-12
por: Chen, Chen, et al.
Publicado: (2015)

LRBA is Essential for Allogeneic Responses in Bone Marrow Transplantation
por: Park, Mi Young, et al.
Publicado: (2016)

Foetal Liver Suspensions in the Treatment of Marrow Aplasia
por: Bridges, J. B., et al.
Publicado: (1965)

Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with MYC locus rearrangement
por: Kato, Takeharu, et al.
Publicado: (2019)

Anti-Ma-associated paraneoplastic cerebellar degeneration in a patient with nodular lymphocyte-predominant Hodgkin lymphoma: a case report
por: Inui, Ryoma, et al.
Publicado: (2020)

Replacement of hematopoietic system by allogeneic stem cell transplantation in myelofibrosis patients induces rapid regression of bone marrow fibrosis
por: Kröger, Nicolaus, et al.
Publicado: (2012)

Case Report: Asymmetric Bone Marrow Involvement in Patients With Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
por: Yan, Han, et al.
Publicado: (2021)

Correction: Allogeneic Non-Adherent Bone Marrow Cells Facilitate Hematopoietic Recovery but Do Not Lead to Allogeneic Engraftment
por: Fricke, Stephan, et al.
Publicado: (2015)

Successful Repigmentation of Vitiligo after Allogeneic Bone Marrow Transplantation for Hodgkin's Lymphoma by Autologous Noncultured Melanocyte-keratinocyte Transplantation
por: Tang, Huijuan, et al.
Publicado: (2015)

Successful Use of Nivolumab in a Patient with Head and Neck Cancer After Allogeneic Bone Marrow Transplantation
por: Dong, Xiaopei, et al.
Publicado: (2021)

The proliferative capacity of pure red cell aplasia bone marrow cells.
por: Katz, L. J., et al.
Publicado: (1981)

Transmission of psoriasis by allogeneic bone marrow transplantation and blood transfusion
por: Li, X, et al.
Publicado: (2015)

Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation
por: Du, Wei, et al.
Publicado: (2018)

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i419jqb71ku135vuutqfkgk69r